Aptahem AB logo

APTA TO 5 - Aptahem AB News Story

SEK0.1 0.0  0.0%

Last Trade - 13/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £9.39m
Enterprise Value £6.93m
Revenue £n/a
Position in Universe 1594th / 1827

BRIEF-Aptahem Enters Agreement With Granzer Regulatory Consulting

Wed 21st October, 2020 11:48am
Oct 21 (Reuters) - Aptahem AB  APTA.TE :
    * APTAHEM ENTERS COLLABORATION AGREEMENT WITH GRANZER
REGULATORY
CONSULTING AND SERVICES TO PREPARE FOR CLINICAL STAGE
    * BY ENTERING THIS AGREEMENT, CO TAKES NEXT STEP TO PREPARE
FOR
REGULATORY DOCUMENTATION LEADING TO CLINICAL TRIALS REGARDING
THEIR LEAD CANDIDATE APTA-1 FOR TREATMENT OF SEPSIS
    * AIM IS TO SUBMIT DOCUMENTATION TO EMA AND FDA IN ORDER TO
GET
REGULATORY SCIENTIFIC ADVISORY MEETINGS WITH AUTHORITIES

Source text for Eikon:  ID:nWkrh9Wvq 
Further company coverage:  APTA.TE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.